• 
• 
• 
• 

Leadership Team and Board of Directors

The TheraGenetics leadership team has an impressive background of experience in pharmaceutical and biotech companies, therapeutics, genetics and diagnostics in the CNS space.

Richard Kivel
Chief Executive Officer

Dr. Heiner Dreismann
Chairman of the Board

Dr. Janet Munro
Co-Founder and Director of Clinical Operations

Robert Forrester
Board Director, Chief Financial Officer CombinatoRx

Dr. Ivan Griffin
Board Director representing IP Group

Stephen Brooke
Board Director representing Swarraton Partners

Dr. Alison Campbell
Board Director representing King's College London